GLDCX | SGGDX | GLDCX / SGGDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 31 years | - |
Gain YTD | 15.737 | 12.890 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 320M | 2.51B | 13% |
Annual Yield % from dividends | 0.47 | 0.87 | 54% |
Returns for 1 year | 27.41 | 20.37 | 135% |
Returns for 3 years | 1.06 | 13.76 | 8% |
Returns for 5 years | 38.34 | 55.33 | 69% |
Returns for 10 years | 80.69 | 86.25 | 94% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSDOX | 13.07 | -0.07 | -0.53% |
Morgan Stanley Emerging Mkt ex China C | |||
IUASX | 43.97 | -0.24 | -0.54% |
VY® Invesco Equity and Income S | |||
FEVIX | 23.19 | -0.14 | -0.60% |
First Eagle US Value I | |||
AFGPX | 16.74 | -0.20 | -1.18% |
Alger International Opportunities B | |||
JFNIX | 74.39 | -2.13 | -2.78% |
Janus Henderson Global Life Sciences I |